These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23454532)

  • 21. Synthesis, antimicrobial activity and molecular modeling study of substituted 5-aryl-pyrimido[5,4-c]quinoline-2,4-diones.
    Ismail MA; Al-Shihry S; Arafa RK; El-Ayaan U
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):530-8. PubMed ID: 22397395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.
    Ewida MA; Ewida HA; Ahmed MS; Allam HA; ElBagary RI; George RF; Georgey HH; El-Subbagh HI
    Bioorg Chem; 2021 Oct; 115():105205. PubMed ID: 34329992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones.
    Agbo EN; Makhafola TJ; Choong YS; Mphahlele MJ; Ramasami P
    Molecules; 2015 Dec; 21(1):E28. PubMed ID: 26712730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
    Graffner-Nordberg M; Fyfe M; Brattsand R; Mellgård B; Hallberg A
    J Med Chem; 2003 Jul; 46(16):3455-62. PubMed ID: 12877583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
    Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
    Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
    Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2018 Oct; 80():11-23. PubMed ID: 29864684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents.
    Singh P; Kaur M; Sachdeva S
    J Med Chem; 2012 Jul; 55(14):6381-90. PubMed ID: 22734697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonclassical antifolates, part 5. Benzodiazepine analogs as a new class of DHFR inhibitors: synthesis, antitumor testing and molecular modeling study.
    El-Subbagh HI; Hassan GS; El-Messery SM; Al-Rashood ST; Al-Omary FA; Abulfadl YS; Shabayek MI
    Eur J Med Chem; 2014 Mar; 74():234-45. PubMed ID: 24469112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vitro antimicrobial evaluation of pyrazolyl-quinazolin-4(3H)-ones.
    Patel NB; Shaikh AR; Barat GG
    Acta Pol Pharm; 2012; 69(6):1067-75. PubMed ID: 23285667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone-based derivatives as DHFR inhibitors.
    Osman EO; Emam SH; Sonousi A; Kandil MM; Abdou AM; Hassan RA
    Drug Dev Res; 2023 Aug; 84(5):888-906. PubMed ID: 37052308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural studies on bioactive compounds. 39. Biological consequences of the structural modification of DHFR-inhibitory 2,4-diamino-6-(4-substituted benzylamino-3-nitrophenyl)-6-ethylpyrimidines ('benzoprims').
    Richardson ML; Croughton KA; Matthews CS; Stevens MF
    J Med Chem; 2004 Jul; 47(16):4105-8. PubMed ID: 15267250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of some novel tetrahydroquinolines as anticancer and antimicrobial agents.
    Faidallah HM; Saqer AA; Alamry KA; Khan KA; Asiri AM
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):367-78. PubMed ID: 23607308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA and RNA synthesis: antifolates.
    Kompis IM; Islam K; Then RL
    Chem Rev; 2005 Feb; 105(2):593-620. PubMed ID: 15700958
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors.
    Moharram EA; El-Sayed SM; Ghabbour HA; El-Subbagh HI
    Bioorg Chem; 2024 Sep; 150():107538. PubMed ID: 38861913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase.
    Wang M; Yang J; Yuan M; Xue L; Li H; Tian C; Wang X; Liu J; Zhang Z
    Eur J Med Chem; 2017 Mar; 128():88-97. PubMed ID: 28152430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.